Table 2

Probability to be free from functional disability in the year before death of cancer patients by selected characteristics

Probability to be free from functional disability (weeks before death)

N.

52 weeks % (95% CI)

24 weeks % (95% CI)

18 weeks % (95% CI)

12 weeks % (95% CI)

6 weeks % (95% CI)

4 weeks % (95% CI)

2 weeks % (95% CI)

Gender

Men

700

95 (93–97)

92 (89–94)

91 (88–93)

68 (63–73)

53 (49–58)

39 (35–44)

27 (23–31)

Women

549

92 (89–94)

88 (84–91)

86 (82–89)

56 (51–62)

43 (37–48)

26 (21–31)

18 (15–22)

Age at death

18–64

242

99 (96–99)

95 (91–97)

93 (89–96)

74 (68–80)

62 (55–68)

43 (36–50)

30 (25–36)

65–84

785

94 (92–96)

92 (89–94)

90 (86–92)

63 (58–68)

47 (43–51)

32 (28–36)

22 (19–25)

85 +

222

85 (79–90)

80 (74–85)

79 (73–84)

50 (42–58)

41 (34–47)

28 (23–33)

19 (14–24)

Primary Tumour

Digestive

453

94 (92–96)

91 (88–94)

90 (87–92)

65 (60–70)

53 (48–58)

35 (30–40)

23 (19–27)

Respiratory

262

97 (93–99)

94 (90–96)

91 (85–95)

69 (61–76)

52 (45–59)

39 (32–46)

28 (23–34)

Breast

124

91 (83–95)

88 (80–93)

87 (80–91)

58 (49–67)

45 (35–55)

24 (15–37)

19 (12–29)

Genitourinary

184

93 (87–97)

87 (80–92)

85 (80–90)

59 (49–68)

41 (33–49)

28 (21–36)

15 (11–23)

Hematological

91

91 (83–95)

90 (82–94)

88 (80–93)

62 (52–72)

52 (42–62)

40 (32–49)

30 (22–40)

Nervous Central System

32

87 (67–96)

76 (59–87)

72 (56–84)

46 (26–68)

35 (19–55)

14 (5–31)

6 (2–19)

Others

103

92 (84–96)

90 (82–95)

90 (81–95)

60 (44–74)

42 (31–55)

37 (27–49)

28 (18–40)

All patients

1,249

94 (92–95)

90 (88–93)

88 (86–91)

63 (58–68)

49 (45–53)

33 (30–37)

23 (20–26)

Costantini et al. BMC Cancer 2008 8:127   doi:10.1186/1471-2407-8-127